Bone Biologics (BBLG) Net Equity Issued and Repurchased (2016 - 2026)
Bone Biologics (BBLG) posted quarterly Net Equity Issued and Repurchased of -$226.0 for Q3 2024, down 64.96% quarter-over-quarter from -$137.0 in Q2 2024.
Powered by 
Analysis
Bone Biologics (BBLG) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends
Bone Biologics (BBLG) has reported Net Equity Issued and Repurchased for 4 consecutive years, with -$226.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Net Equity Issued and Repurchased changed N/A year-over-year to -$226.0; the TTM figure through Dec 2025 stood at -$226.0 (down 100.02% YoY), while the FY2025 annual figure was $4.4 million, up 189.39% from the prior year.
- Net Equity Issued and Repurchased declined to -$226.0 in Q3 2024 per BBLG's latest filing, from -$137.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $1.5 million in Q1 2024 and bottomed at -$226.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | 347,549.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 347,549.00 |
| Sep 30, 2025 | 4.01 Mn |
| Sep 30, 2024 | -226.00 |
| Jun 30, 2024 | -137.00 |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 591,998.00 |
| Sep 30, 2018 | 3.87 Mn |
| Jun 30, 2018 | 7,500.00 |
| Mar 31, 2018 | 500,000.00 |
| Mar 31, 2016 | 2.50 Mn |